Medical weight management’s effects on appearance, muscle, and skin based on patient reports to guide overall prevention

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are becoming central to obesity care.

• There is a growing concern about potential aesthetic and muscle-related side effects associated with GLP-1RAs.
• Protocols to mitigate or prevent these effects may be necessary as their use in obesity treatment increases.
• The recognition of these potential sequelae indicates a need for careful management in patients receiving GLP-1RA therapy.

Simplified